Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain

Launched by UNIVERSITY OF NEVADA, LAS VEGAS · Aug 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help people with patellofemoral pain syndrome, which is pain around the kneecap often caused by the knee caving in during activities. The researchers want to see if a treatment called transcranial Direct Current Stimulation (tDCS), when combined with exercise, can better improve knee movement compared to exercise alone. This technique targets the part of the brain that controls the hip muscles, potentially leading to better results in reducing pain and improving movement.

To participate in this trial, individuals must be between 18 and 45 years old and have experienced knee pain for at least three months, with noticeable knee movement issues during activities. However, those with a history of knee injuries or surgeries, certain medical conditions, or who are pregnant cannot join the study. Participants can expect to engage in exercises while receiving the tDCS treatment, and the study aims to gather valuable information that could enhance existing treatments for knee pain in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. are between 18 and 45 years old
• • 2. have had patellofemoral pain (PFP; kneecap pain) on one side for at least 3 months, and 3) the knee does cave in when performing functional movements.
• Exclusion Criteria:
• • 1. do not have pain coming from the kneecap during screening;
• • 2. have a history of knee injury or surgery,
• • 3. have a history of seizures and/or taking anti-seizure medication,
• • 4. have an implanted device that interacts with electric current,
• • 5. have a history of balance disorder,
• • 6. currently are pregnant or think they may be pregnant.